John Osborn

John Osborn is a Senior Advisor at Hogan Lovells, offering expertise on corporate, commercial, public policy, and regulatory matters in the life sciences and healthcare sectors since December 2013. As a Venture Partner at BioVentures Investors, John engages in growth and venture-stage investments focused on innovative medtech companies. An active contributor to Forbes, John also serves as an Affiliate Professor at the University of Washington School of Law and a guest lecturer at both the University of Michigan and UCLA Fielding School of Public Health. Previously, John held senior roles at Onyx Pharmaceuticals and Dendreon, and served as a Commissioner for the U.S. Advisory Commission on Public Diplomacy. John holds multiple degrees, including a JD from the University of Virginia School of Law and postgraduate studies at Princeton University.